Level Biotechnology (3118) — Cash Flow Quality Index
Level Biotechnology (3118) has a Cash Flow Quality Index of 0.44x as of September 2025. Operating cash flow of NT$11.81 Million is below net income of NT$26.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 3118 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Level Biotechnology Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Level Biotechnology across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Level Biotechnology to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Level Biotechnology (2017–2024)
Year-by-year earnings quality comparison for Level Biotechnology. For live market cap and the full company financial profile, see Level Biotechnology (3118) total market value.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | NT$64.10 Million | NT$64.81 Million | ▲ +10.8% |
| 2023 | 0.89x | NT$70.21 Million | NT$78.65 Million | ▲ +0.4% |
| 2022 | 0.89x | NT$65.07 Million | NT$73.16 Million | ▼ -51.6% |
| 2021 | 1.84x | NT$155.95 Million | NT$84.89 Million | ▲ +60.1% |
| 2020 | 1.15x | NT$83.23 Million | NT$72.54 Million | ▼ -50.1% |
| 2019 | 2.30x | NT$109.02 Million | NT$47.40 Million | ▲ +234.3% |
| 2018 | 0.69x | NT$26.77 Million | NT$38.91 Million | ▼ -34.1% |
| 2017 | 1.04x | NT$71.29 Million | NT$68.31 Million | — |